World's Best Scientists 2026 revealed!
Claude C.A. Bernard

Claude C.A. Bernard

D-Index & Metrics

Immunology

D-Index
71
Citations
18838
World Ranking
2307
National Ranking
91

Research.com Recognitions

  • 1998 - Fellow of American Physical Society (APS) Citation For his many contributions to the numerical study of quantum chromodynamics, particularly of the weak decays of strongly interacting particles
  • 1980 - Fellow of Alfred P. Sloan Foundation

Overview

Claude C.A. Bernard is a researcher affiliated with Monash University in Australia. Their work spans various fields including Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. The interdisciplinary nature of their research touches on several specialized subfields such as Immunology, Cellular and Molecular Neuroscience, Molecular Biology, Ophthalmology, and Genetics.

Several recurring themes appear in their main topics of study. These include Nuclear Receptors and Signaling, Diabetes and associated disorders, Diabetes Management and Research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and Immune Cells in Cancer.

The scientist's recent publications demonstrate a focus on immunological and molecular mechanisms as well as disease treatment approaches. Notable papers include:

  • Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study (2020) published in Diabetologia
  • Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity (2021) published in Nanomedicine Nanotechnology Biology and Medicine
  • Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3β in the MPP+ treated SH-SY5Y Parkinson's model (2022) published in Non-coding RNA Research
  • TGFβ and Wnt Signaling Pathways Cooperatively Enhance Early Dopaminergic Differentiation of the Unrestricted Somatic Stem Cells (2020) published in Journal of Molecular Neuroscience
  • Frequency of Eye Diseases in Subjects Aged 40 and Over (2025) published in Open Journal of Ophthalmology

Collaboration plays a role in their research, with frequent co-authors including Azita Parvaneh Tafreshi, Michèlle Rosenzwajg, Randa Salet, Roberta Lorenzon, and Nicolas Tchitchek.

The distribution of publications aligns with venues such as Diabetologia, Nanomedicine Nanotechnology Biology and Medicine, Non-coding RNA Research, Journal of Molecular Neuroscience, and Open Journal of Ophthalmology.

Throughout their career, Claude C.A. Bernard has been recognized by awards such as Fellow of the American Physical Society in 1998, which acknowledged their contributions to the numerical study of quantum chromodynamics, focusing on weak decays of strongly interacting particles. They were also named a Fellow of the Alfred P. Sloan Foundation in 1980.

Best Publications

  • The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

    Dorothée Chabas;Sergio E. Baranzini;Dennis Mitchell;Claude C. A. Bernard

  • IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

    David O. Willenborg;Sue Fordham;C. C A Bernard;William B. Cowden

  • TNF IS A POTENT ANTI-INFLAMMATORY CYTOKINE IN AUTOIMMUNE-MEDIATED DEMYELINATION

    Junliang Liu;Michael W. Marino;Grace Wong;Dianne Grail

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

    Veronika Brundula;N Barry Rewcastle;Luanne M Metz;Claude Charles Andre Bernard

  • Granulocyte Macrophage Colony-Stimulating Factor A New Putative Therapeutic Target in Multiple Sclerosis

    Jonathan Luke McQualter;Rima Darwiche;Christine Ewing;Manabu Onuki

  • Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients

    Jorge R. Oksenberg;Simon Stuart;Ann B. Begovich;Robert B. Bell

  • Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

    Jorge R. Oksenberg;Michael A. Panzara;Ann B. Begovich;Dennis Mitchell

  • MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

    Nicolas Molnarfi;Ulf Schulze-Topphoff;Martin S Weber;Juan C Patarroyo

  • Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

    Agnès Hartemann;Gilbert Bensimon;Christine A Payan;Sophie Jacqueminet

  • Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

    N Kerlero de Rosbo;R Milo;M B Lees;D Burger

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions.

    Sergio E. Baranzini;Matthew C. Jeong;Catalin Butunoi;Ronald S. Murray

  • Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

    C. C. A. Bernard;T. G. Johns;A. Slavin;M. Ichikawa

  • B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

    Martin S. Weber;Thomas Prod'homme;Juan C. Patarroyo;Nicolas Molnarfi

  • Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy

    Lawrence Steinman;Roland Martin;Claude Charles Andre Bernard;Paul Conlon

  • The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.

    Tara Karnezis;Tara Karnezis;Wim Mandemakers;Jonathan L McQualter;Binhai Zheng

  • Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.

    William H. Robinson;Paulo Fontoura;Byung J. Lee;Henry E Neuman De Vegvar;Henry E Neuman De Vegvar

  • IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.

    Yoshinobu Okuda;Saburo Sakoda;Claude C. A. Bernard;Harutoshi Fujimura

  • T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

    Jorge R. Oksenberg;Martina Sherritt;Ann B. Begovich;Henry A. Erlich

Frequent Co-Authors

Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
Lawrence Steinman
Lawrence Steinman Stanford University
Scott S. Zamvil
Scott S. Zamvil University of California, San Francisco
Terrance Grant Johns
Terrance Grant Johns Telethon Kids Institute
Raymond A. Sobel
Raymond A. Sobel Stanford University
John S. Forsythe
John S. Forsythe Monash University
Richard L. Boyd
Richard L. Boyd Monash University
Michelle Rosenzwajg
Michelle Rosenzwajg Sorbonne University
David J. Craik
David J. Craik University of Queensland
Sergio E. Baranzini
Sergio E. Baranzini University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing related nursing degrees online is a practical option. Many programs cater to different starting points and career goals, including options for individuals with no prior nursing background. Exploring online absn programs for non nurses offers a fast track into the nursing field for career changers, combining foundational knowledge with clinical practice.

If you’re looking to accelerate your entry into nursing, numerous accelerated programs are available. Among these, the 12-month accelerated nursing programs stand out for those aiming to complete their Bachelor of Science in Nursing (BSN) in a reduced timeframe without sacrificing quality.

Programs for Licensed Practical Nurses (LPNs) can also provide a stepping stone into the broader nursing profession. Identifying which lpn programs are easiest to get into allows prospective students to make informed decisions based on admission criteria and program flexibility.

For advanced nursing roles, considering the easiest nurse practitioner program can help nurses elevate their career while balancing work and study. These programs offer pathways to specialized practice areas, complementing a strong foundation in oncology, immunology, or infectious diseases.

Best Scientists Citing Claude C.A. Bernard

Trending Scientists

Recently Published Articles